Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

NAEnrolling by invitationINTERVENTIONAL
Enrollment

402

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

March 31, 2027

Conditions
Alzheimer DiseaseCognitive ImpairmentMild Cognitive ImpairmentDementia, MildDementia ModerateDementia AlzheimersDementia of Alzheimer TypeAD
Interventions
DEVICE

Sensory Stimulation System (GS120) - Active

Sensory Stimulation System (GS120) - Active settings

Trial Locations (53)

12208

Neurological Associates of Albany, Albany

12553

Mid Hudson Medical Research, New Windsor

13057

Velocity Clinical Research - Syracuse, East Syracuse

19046

The Clinical Trial Center, Jenkintown

22031

ReCogniton Health, Fairfax

23055

Multi-Specialty Research Associates, Inc., Lake City

28105

Alzheimer's Memory Center - AMC Research, Matthews

29203

Prisma Health Neurology, Columbia

29935

Coastal Neurology, Port Royal

30033

NeuroStudies, Decatur

30329

Emory Alzheimer's Disease Research Center, Atlanta

32073

Coastal Family Medicine - Orange Park, Orange Park

32117

Arrow Clinical Trials, Daytona Beach

32127

Progressive Medical Research, Port Orange

32504

Emerald Coast Neurology, Pensacola

32789

Conquest Research, Winter Park

32792

Charter Research - Lady Lake, Lady Lake

Charter Research - Winter Park, Winter Park

33064

Quantum Laboratories, Pompano Beach

33445

Brain Matters Research, Delray Beach

33462

JEM Research Institute, Atlantis

33713

Suncoast Neuroscience Associates, St. Petersburg

33912

Neuropsychiatric Research Center of Southwest Florida, Fort Myers

34239

Intercoastal Medical Group - Sarasota, Sarasota

34711

South Lake Pain Institute, Clermont

34997

Brain Matters Research (Kane Center), Stuart

37920

University of Tennessee Medical Center, Knoxville

39401

Hattiesburg Clinic, Hattiesburg

43210

The Ohio State University Wexner Medical Center, Columbus

44122

Insight Clinical Trials, LLC, Beachwood

48334

QUEST Research Institute, Farmington

60031

Great Lakes Clinical Trials- Flourish Research- Gurnee, Gurnee

60640

Great Lakes Clinical Trials- Flourish Research- Chicago, Chicago

76104

North Texas Clinical Trials, Fort Worth

77477

TRS Health, Stafford

77478

Mercury Clinical Research, Sugar Land

78229

UT Health San Antonio, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, San Antonio

80218

Mile High Research Center, Denver

84107

Wasatch Clinical Research, Salt Lake City

85013

Barrow Neurological Institute, Phoenix

85044

CCT Research - Foothills Research Center, Phoenix

85351

Banner Sun Health Research Institute, Sun City

89113

Las Vegas Medical Research, Las Vegas

90740

Office of Elizabeth Zarate-Rowell, MD, Seal Beach

92626

ATP Clinical Research, Inc., Costa Mesa

92705

Syrentis Clinical Research, Santa Ana

92805

Advanced Research Center, Inc, Anaheim

92835

Neurology Center of North Orange County, Fullerton

04402

Northern Light Acadia Hospital, Bangor

02459

Boston Center for Memory, Newton

02360

Office of Donald S. Marks, M.D., P.C., Plymouth

01103

Sisu BHR, LLC, Springfield

07081

The Cognitive and Research Center of New Jersey, Springfield

Sponsors
All Listed Sponsors
lead

Cognito Therapeutics, Inc.

INDUSTRY

NCT06245031 - Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015) | Biotech Hunter | Biotech Hunter